« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 5
, Pages
1234-1240.e1
, May 2009
Matching donor to recipient in lung transplantation: How much does size matter?
-
Distribution of differences in aTLC versus pTLC by diagnosis. PAH, Pulmonary arterial hypertension; IPF, idiopathic pulmonary fibrosis; aTLC, actual total lung capacity; pTLC, predicted total lung cap
Distribution of differences in aTLC versus pTLC by diagnosis. PAH, Pulmonary arterial hypertension; IPF, idiopathic pulmonary fibrosis; aTLC, actual total lung capacity; pTLC, predicted total lung capacity.
-
Cumulative distribution of donor-to-recipient TLC according to diagnosis. A, Donor-to-recipient pTLCRatio. B, Donor-to-recipient aTLCRatio. IPF, Idiopathic pulmonary fibrosis; pTLCRatio, donor-to-reciCumulative distribution of donor-to-recipient TLC according to diagnosis. A, Donor-to-recipient pTLCRatio. B, Donor-to-recipient aTLCRatio. IPF, Idiopathic pulmonary fibrosis; pTLCRatio, donor-to-recipient predicted total lung capacity ratio; aTLCRatio, donor-to-recipient actual total lung capacity ratio.
-
Overall unadjusted survival by terciles of donor-to-recipient pTLCRatio. Symbols represent deaths. Vertical bars represent 68% confidence limits equivalent to ± 1 standard error. Numbers in parentheseOverall unadjusted survival by terciles of donor-to-recipient pTLCRatio. Symbols represent deaths. Vertical bars represent 68% confidence limits equivalent to ± 1 standard error. Numbers in parentheses represent patients remaining at risk (P [log-rank] = .4). o = patients with largest 15% of pTLCRatio. • = patients with the middle 70% of pTLCRatio. □ = patients with the smallest 15% of pTLCRatio.
-
Unadjusted survival in patients with emphysema stratified by donor-to-recipient aTLCRatio. o = patients with extreme values of aTLCRatio (n = 44). □ = the 70% of patients with more typical values (n =Unadjusted survival in patients with emphysema stratified by donor-to-recipient aTLCRatio. o = patients with extreme values of aTLCRatio (n = 44). □ = the 70% of patients with more typical values (n = 108). Format is as in Figure 3. P (Wilcoxon) = .01.
-
Predicted mean FEV1% after lung transplantation for emphysema from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual curvesPredicted mean FEV1% after lung transplantation for emphysema from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual curves represent specific values of donor-to-recipient aTLCRatio. FEV1%, Forced expiratory volume in 1 second; pTLCRatio, donor-to-recipient predicted total lung capacity ratio; aTLCRatio, donor-to-recipient actual total lung capacity ratio.
-
Predicted mean FEV1% after lung transplantation for IPF from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual curves represPredicted mean FEV1% after lung transplantation for IPF from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual curves represent specific values of donor-to-recipient aTLCRatio. FEV1%, Forced expiratory volume in 1 second; pTLCRatio, donor-to-recipient predicted total lung capacity ratio; aTLCRatio, donor-to-recipient actual total lung capacity ratio.
-
Predicted mean FEV1% after lung transplantation for bronchiectasis from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual cuPredicted mean FEV1% after lung transplantation for bronchiectasis from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual curves represent specific values of donor-to-recipient aTLCRatio. FEV1%, Forced expiratory volume in 1 second; pTLCRatio, donor-to-recipient predicted total lung capacity ratio; aTLCRatio, donor-to-recipient actual total lung capacity ratio.
-
Number of patients with spirometry measurements available at and beyond various time points, and number of spirometry measurements available for analysis (black bars, spirometry measurements; grey barNumber of patients with spirometry measurements available at and beyond various time points, and number of spirometry measurements available for analysis (black bars, spirometry measurements; grey bars, patients).
Supported in part by the Kenneth Gee and Paula Shaw, PhD, Chair in Heart Research.
PII: S0022-5223(08)01750-9
doi: 10.1016/j.jtcvs.2008.10.024
© 2009 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 5
, Pages
1234-1240.e1
, May 2009
